Results 391 to 400 of about 871,767 (407)

Juxtamembrane autoinhibition in receptor tyrosine kinases

Nature Reviews Molecular Cell Biology, 2004
Stevan R Hubbard
exaly  

The TAM family: phosphatidylserine-sensing receptor tyrosine kinases gone awry in cancer

Nature Reviews Cancer, 2014
Deborah DeRyckere
exaly  

Second and third-generation epidermal growth factor receptor tyrosine kinase inhibitors in advanced nonsmall cell lung cancer

Current Opinion in Oncology, 2015
Bin-Chi Liao, Chia‐Chi Lin, J. Yang
semanticscholar   +1 more source

Targeting Bruton's tyrosine kinase in B cell malignancies

Nature Reviews Cancer, 2014
Rudi W Hendriks, Saravanan Y Pillai
exaly  

Common EGFR-mutated subgroups (Del19/L858R) in advanced non-small-cell lung cancer: chasing better outcomes with tyrosine kinase inhibitors.

Future Oncology, 2015
N. Reguart, J. Remon
semanticscholar   +1 more source

Not all epidermal growth factor receptor mutations in lung cancer are created equal: Perspectives for individualized treatment strategy

Cancer Science, 2016
Tetsuya Mitsudomi
exaly  

A dynamic N6-methyladenosine methylome regulates intrinsic and acquired resistance to tyrosine kinase inhibitors

Cell Research, 2018
Fei Yan, Aref Al-Kali, Zijie Zhang
exaly  

Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition

Nature Reviews Cancer, 2007
Thomas Force, Daniela S Krause, Richard A Van Etten   +2 more
exaly  

Practical Guidelines for Therapeutic Drug Monitoring of Anticancer Tyrosine Kinase Inhibitors: Focus on the Pharmacokinetic Targets

Clinical Pharmacokinetics, 2014
Huixin Yu, N. Steeghs, C. Nijenhuis, J. Schellens, J. Beijnen, A. Huitema   +5 more
semanticscholar   +1 more source

Protein tyrosine phosphatases: from genes, to function, to disease

Nature Reviews Molecular Cell Biology, 2006
exaly